18 clinical trials found.
-
Corevitas Inflammatory Bowel Disease (IBD) Registry
The primary objective for this registry is to prospectively study the natural history of IBD, the prevalence and incidence of comorbidities, and targeted adverse events ...Phase N/A
TRIAL ROLE: Sub Investigator
-
ICONIC-CD Protocol 77242113CRD3001: A Phase 2b/3 Randomized Double-blind Placebo-Controlled Parallel Group Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
The purpose of this research study is to help researchers understand more about the possible effectiveness and safety of icotrokinra in patients with moderately to ...Phase
TRIAL ROLE: Sub Investigator
-
C5041018 A PHASE 2 OPEN LABEL SINGLE ARM STUDY TO EVALUATE THE EFFICACY PHARMACOKINETICS AND SAFETY OF ETRASIMOD IN PEDIATRIC PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
The purpose of this study is to assess the effects of the study drug, etrasimod, for treating pediatric ulcerative colitis (UC) participants. Participants will take ...Phase
TRIAL ROLE: Sub Investigator
-
Standardized Microbiota Transplant Therapy in Crohn s Disease.
This study aims to examine the relationship between the intestinal microbiota and Crohn’s disease (CD) phenotype, and to evaluate whether modifying the microbiota can ...Phase N/A TRIAL ROLE: Sub Investigator
-
ICONIC-UC: Phase 3 randomized double-blind placebo-controlled study in adults and open-label in adolescents to evaluate efficacy and safety of icotrokinra for induction and maintenance in moderate to severe ulcerative colitis.
The purpose of this study is to learn more about a study medicine called icotrokinra and to find out if it is safe and helps ...Phase
TRIAL ROLE: Sub Investigator
-
An Open-Label Phase 4 Single-Arm Multicenter Study to Evaluate the Induction of Response and Remission of Vedolizumab Dual Targeted Therapy with Tofacitinib in Adult Patients with Moderately to Severely Active Ulcerative Colitis
This is a phase 4, interventional, open-label, single-arm, multicenter study in adult participants with moderately to severely active ulcerative colitis (UC) who have experienced inadequate ...Phase
TRIAL ROLE: Sub Investigator
-
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
This study will enroll patients who are starting treatment with Zymfentra (infliximab-dyyb) for irritable bowel disease (IBD). This study will collect information about responses to ...Phase N/A TRIAL ROLE: Sub Investigator
-
EFC18325 A multicenter multinational randomized double-blind placebo-controlled Phase 3 induction study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis
The purpose of this research study is to study an experimental drug SAR447189, also called duvakitug, for the treatment of moderate to severe Ulcerative Colitis ...Phase
TRIAL ROLE: Sub Investigator
-
CA45905: Phase III randomized double-blind multi-center study evaluating PK PD immunogenicity safety and efficacy of RO7790121 induction and maintenance therapy in children (2 17 years) with moderately to severely active ulcerative colitis.
This study is to assess the efficacy and safety of RO7790121 (formerly PF-06480605 and RVT-3101) in pediatric patients with moderately to severely active ulcerative colitis ...Phase
TRIAL ROLE: Sub Investigator
-
EFC18326 - A multicenter multinational randomized double-blind placebo-controlled Phase 3 induction study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn s Disease
The purpose of this research study is to study an experimental drug SAR447189, also called duvakitug, for the treatment of moderate to severe Crohn’s ...Phase
TRIAL ROLE: Sub Investigator
